Clinical Performance and Safety of STYLAGE® HydroMax
NCT: NCT07153237 · ACTIVE_NOT_RECRUITING
NCT IDNCT07153237
StatusACTIVE_NOT_RECRUITING
Start Date2025-09-09
Completion2026-11-09
SponsorLaboratoires Vivacy (INDUSTRY)
First posted
Last updated
Brief Summary
FHAME is a post-market clinical investigation designed to strengthen the clinical evidence supporting the effectiveness of STYLAGE® HydroMax in the treatment of superficial wrinkles, primarily on the cheeks.
Frequently Asked Questions
What is Clinical Performance and Safety of STYLAGE® HydroMax?
Clinical Performance and Safety of STYLAGE® HydroMax is a clinical trial registered under NCT07153237. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT07153237?
The current status of NCT07153237 (Clinical Performance and Safety of STYLAGE® HydroMax) is: ACTIVE_NOT_RECRUITING.
When did Clinical Performance and Safety of STYLAGE® HydroMax start?
Clinical Performance and Safety of STYLAGE® HydroMax started on 2025-09-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.